Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|18|9|786-797

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.18, Iss.9, 2017-12, pp. : 786-797

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antioxidant strategies in protection against neurodegenerative disorders

By Tan Dun-Xian   Manchester Lucien C   Sainz Rosa   Mayo Juan C   Alvares Frederick L   Reiter Russel J  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 10, 2003-10 ,pp. : 1513-1543

Informa Healthcare

Access to resources Recommend Favorite

The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies

By  

Current Medicinal Chemistry, Vol. 14, Iss. 23, 2007-10 ,pp. : 2456-2470

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticles, Neurotoxicity and Neurodegenerative Diseases

By  

Current Drug Metabolism, Vol. 16, Iss. 8, 2015-10 ,pp. : 676-684

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Neurodegenerative Disorders: Synthesis, Drug Delivery Strategies and Biological Evaluation of New Therapeutic Agents

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 2, 2017-07 ,pp. : 89-89

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidants as treatment for neurodegenerative disorders

By Moosmann Bernd   Behl Christian  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 10, 2002-10 ,pp. : 1407-1435

Informa Healthcare

Access to resources Recommend Favorite